| Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability D Bhanja, H Wilding, A Baroz, M Trifoi, G Shenoy, B Slagle-Webb, ... Cancers 15 (13), 3427, 2023 | 21 | 2023 |
| Small cell lung cancer transformation following treatment in EGFR-mutated non-small cell lung cancer I Mambetsariev, L Arvanitis, J Fricke, R Pharaon, AR Baroz, M Afkhami, ... Journal of Clinical Medicine 11 (5), 1429, 2022 | 15 | 2022 |
| Mutagenesis, hydrogen–deuterium exchange, and molecular docking investigations establish the dimeric interface of human platelet-type 12-lipoxygenase WC Tsai, AM Aleem, C Whittington, WA Cortopassi, C Kalyanaraman, ... Biochemistry 60 (10), 802-812, 2021 | 15 | 2021 |
| Evaluation of somatic mutations in solid metastatic pan-cancer patients MR Roosan, I Mambetsariev, R Pharaon, J Fricke, AR Baroz, J Chao, ... Cancers 13 (11), 2776, 2021 | 10 | 2021 |
| Evaluation of omics-based strategies for the management of advanced lung cancer R Salgia, I Mambetsariev, R Pharaon, J Fricke, AR Baroz, I Hozo, C Chen, ... JCO Oncology Practice 17 (2), e257-e265, 2021 | 10 | 2021 |
| Therapeutic potential of olaparib in combination with pembrolizumab in a young patient with a maternally inherited BRCA2 germline variant: a research report T Waddington, I Mambetsariev, R Pharaon, J Fricke, AR Baroz, H Romo, ... Clinical lung cancer 22 (5), e703-e707, 2021 | 6 | 2021 |
| Elevated eosinophil count following pembrolizumab treatment for non-small cell lung cancer AR Baroz, I Mambetsariev, J Fricke, R Pharaon, TT Tan, T Kidambi, ... Cureus 13 (7), 2021 | 6 | 2021 |
| Complex oncological decision-making utilizing fast-and-frugal trees in a community setting—role of academic and hybrid modeling R Salgia, I Mambetsariev, T Tan, A Schwer, DP Pearlstein, H Chehabi, ... Journal of Clinical Medicine 9 (6), 1884, 2020 | 6 | 2020 |
| Molecular and clinical features of hospital admissions in patients with thoracic malignancies on immune checkpoint inhibitors D Zhao, H Li, I Mambetsariev, C Chen, R Pharaon, J Fricke, AR Baroz, ... Cancers 13 (11), 2653, 2021 | 2 | 2021 |
| The Influence of a Previous COVID-19 Infection on Rhinoplasty Outcomes J Tucker, A Baroz, JG Lighthall Facial Plastic Surgery & Aesthetic Medicine, 2024 | | 2024 |
| Development of clinically accessible nomograms to predict risk of brain metastases at baseline and follow-up in patients with non-small cell lung cancer. A Mansouri, HE Wilding, N Mikolajewicz, D Bhanja, C Moeckel, A Ozair, ... Journal of Clinical Oncology 42 (16_suppl), 2035-2035, 2024 | | 2024 |
| IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation D Bhanja, H Wilding, C Moeckel, J Hong, A Baroz, C Stahl, A Ozair, J Dao, ... Neuro-Oncology 25 (Suppl 5), v141, 2023 | | 2023 |
| IS DUAL AGENT IMMUNOTHERAPY SHIFTING THE EPIDEMIOLOGY OF MELANOMA BRAIN METASTASES? A REAL-WORLD ANALYSIS AND SINGLE-INSTITUTION VALIDATION D Bhanja, H Wilding, C Moeckel, J Hong, A Baroz, C Stahl, A Ozair, J Dao, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| EXTH-76. TRANSLATIONAL BARRIERS IN 5-ALA PHOTODYNAMIC THERAPY FOR GLIOMAS: A SYSTEMATIC REVIEW OF THE IN VIVO LANDSCAPE AND FUTURE DIRECTIONS FOR CLINICAL APPLICABILITY D Bhanja, H Wilding, A Baroz, M Trifoi, G Shenoy, B Slage-Webb, ... Neuro-Oncology 25 (Supplement_5), v242-v242, 2023 | | 2023 |
| P06. 01. A HAS THE USE OF DUAL AGENT IMMUNOTHERAPY BEEN ALTERING THE INCIDENCE OF MELANOMA BRAIN METASTASES? A POPULATION-LEVEL ANALYSIS AND SINGLE-INSTITUTION VALIDATION S Salmanian, D Bhanja, H Wilding, C Moeckel, J Hong, J Dao, A Baroz, ... Neuro-Oncology 25 (Suppl 2), ii44, 2023 | | 2023 |
| SDPS-39 AN UPDATED VALIDATION OF PREDICTIVE ALGORITHMS FOR BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER: SYSTEMATIC REVIEW AND INDEPENDENT COHORTVALIDATION ANALYSIS H Wilding, N Mikolajewicz, D Bhanja, C Moeckel, N Hamidi, C Tankam, ... Neuro-Oncology Advances 5 (Supplement_3), iii24-iii24, 2023 | | 2023 |
| Novel Algorithm for Predicting Brain Metastases in Non-Small Cell Lung Cancer Patients. A Systematic Review and Independent Cohort Validation Analysis S Salmanian, H Wilding, N Mikolajewicz, D Bhanja, C Tankam, ... Brain and Spine 3, 102141, 2023 | | 2023 |
| NCOG-08. IMPACT OF IMMUNOTHERAPY ON PREVALENCE OF BRAIN METASTASES IN MALIGNANT MELANOMA: A REAL-WORLD POPULATION-LEVEL ANALYSIS D Bhanja, A Baroz, C Stahl, H Wilding, A Mansouri Neuro-Oncology 24 (Suppl 7), vii198, 2022 | | 2022 |
| DISP-07. SURVIVAL ANALYSIS OF GLIOBLASTOMA PATIENTS IN PENNSYLVANIA ACCORDING TO AREA DEPRIVATION INDEX AND IDH STATUS A Baroz, C Stahl, D Bhanja, H Wilding, A Mansouri Neuro-Oncology 24 (Suppl 7), vii128, 2022 | | 2022 |
| DISP-01. IMMUNOTHERAPY ADMINISTRATION RATES IN PATIENTS WITH BRAIN METASTASES: IMPACT OF END STAGE RENAL DISEASE AND DIALYSIS A Baroz, D Bhanja, C Stahl, H Wilding, A Mansouri Neuro-Oncology 24 (Supplement_7), vii127-vii127, 2022 | | 2022 |
